Accordingly, Miyoshi N et al have recently suggested that overexpression of the TGM2 gene in CRC patients is associated with a shorter overall survival [44] and expression of the PTPRA gene has been recurrently associated with progression of gastric cancer, including lymphovascular invasion and liver/peritoneal dissemination [45], [46]. This evidence concerns the gene PTPRA and colorectal carcinoma.